Comparing the current results to its competitors, Nuo Therapeutics Inc reported Revenue increase in the 1 quarter 2026 by 168.82 % year on year. The sales growth was above Nuo Therapeutics Inc 's competitors' average revenue growth of 3.45 %, achieved in the same quarter.
Nuo Therapeutics Inc , slower than the average decrease reported by the company's competitors of -14.72 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -14.72 %
Nuo Therapeutics Inc 's Comment on Competition and Industry Peers
Aurix operates in the chronic wound care market, competing with other FDA-cleared platelet-derived products as well as pharmaceutical, biopharmaceutical, and medical device companies offering advanced wound care dressings, devices, and biologics. Smith+Nephew serves as the exclusive distributor of a private label product of Aurix that directly competes with Aurix's own product. Key companies in the advanced wound care sector include 3M, Mölnlycke, and ConvaTec. Other competitors providing biologic products such as tissue-based solutions include MiMedx, Organogenesis, and Integra Life Sciences, alongside numerous smaller firms. The chronic wound market features established therapies with existing use patterns and provider contracts. Several companies have developed or are developing products that may directly compete with Aurix's current offerings. Many competitors possess significantly greater capital resources, larger marketing teams, and more extensive commercialization experience.
Anika Therapeutics Inc is a medical technology company that focuses on developing and commercializing therapeutic products to treat tissue-related disorders. Their business model revolves around conducting extensive research and development to create innovative therapies, partnering with healthcare professionals and distributors to bring their products to market, and generating revenue through the sale of these products worldwide. They also collaborate with other companies and academic institutions to enhance their product portfolio and expand their reach in the healthcare industry.
Avita Medical Inc is a medical technology company that specializes in regenerative medicine. Their business model focuses on developing and commercializing innovative products for the treatment of burns, chronic wounds, and other skin-related conditions.
Sanara Medtech Inc's business model focuses on developing and providing innovative medical technologies and solutions for wound care, aiming to improve patient outcomes and address unmet needs in the healthcare industry.
Strata Skin Sciences Inc's business model revolves around developing and marketing innovative medical devices and products for dermatology and aesthetic procedures.
Tela Bio Inc is a company that operates on a business model centered around developing and commercializing novel medical products for soft tissue repair and reconstruction.
Sources:
Nuo Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Nuo Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
